Cargando…
Peptide-based vaccine targeting IL17A attenuates experimental spondyloarthritis in HLA-B27 transgenic rats
OBJECTIVES: Spondyloarthritis (SpA) is known as series of immune-mediated inflammatory disease of the axial and peripheral joints. Human leucocyte antigen (HLA)-B27 is a genetic risk factor for SpA. Recent evidence suggests that the interleukin −17 (IL17) axis strongly contributes to SpA. This study...
Autores principales: | Hayashi, Hiroki, Sun, Jiao, Yanagida, Yuka, Yoshida, Shota, Baba, Satoshi, Tenma, Akiko, Toyoura, Masayoshi, Kawabata, Sotaro, Ehara, Takako, Asaki, Ryoko, Sakaguchi, Makoto, Tomioka, Hideki, Shimamura, Munehisa, Morishita, Ryuichi, Rakugi, Hiromi, Tomita, Tetsuya, Nakagami, Hironori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900070/ https://www.ncbi.nlm.nih.gov/pubmed/36737108 http://dx.doi.org/10.1136/rmdopen-2022-002851 |
Ejemplares similares
-
AJP001, a novel helper T‐cell epitope, induces a humoral immune response with activation of innate immunity when included in a peptide vaccine
por: Tenma, Akiko, et al.
Publicado: (2019) -
The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice
por: Yoshida, Shota, et al.
Publicado: (2020) -
Preclinical study of a DNA vaccine targeting SARS-CoV-2
por: Hayashi, Hiroki, et al.
Publicado: (2022) -
A novel angiotensin II peptide vaccine without an adjuvant in mice
por: Nakamaru, Ryo, et al.
Publicado: (2021) -
Therapeutic vaccine for chronic diseases after the COVID-19 Era
por: Nakagami, Hironori, et al.
Publicado: (2021)